Format

Send to

Choose Destination
Blood Adv. 2019 Sep 10;3(17):2627-2631. doi: 10.1182/bloodadvances.2019000013.

Persistence of skewed X-chromosome inactivation in pre-B acute lymphoblastic leukemia of a female ATRX mutation carrier.

Author information

1
Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
2
Admera Health, LLC, South Plainfield, NJ.
3
Genetron Health Technologies Inc., Research Triangle Park, NC.
4
Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.
5
Flow Cytometry Unit, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
6
Hematologic Malignancies/BMT Program, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.
7
Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.
8
Leukemia, Lymphoma and Myeloma Program, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; and.
9
Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center